| Dr Neychelle Chahal Rocca, MD | |
|
255 W Brown Rd, Mesa, AZ 85201-3404 | |
| (480) 985-1093 | |
| (480) 296-7665 |
| Full Name | Dr Neychelle Chahal Rocca |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine |
| Experience | 27 Years |
| Location | 255 W Brown Rd, Mesa, Arizona |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063645778 | NPI | - | NPPES |
| 781485 | Medicaid | AZ |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | MD446744 (Pennsylvania) | Secondary |
| 208M00000X | Hospitalist | 48327 (Arizona) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Verde Valley Medical Center | Cottonwood, AZ | Hospital |
| Banner - University Medical Center Phoenix | Phoenix, AZ | Hospital |
| Flagstaff Medical Center | Flagstaff, AZ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Banner - University Hospital Based Physicians Llc | 1052614294 | 244 |
| Northern Arizona Healthcare Corporation | 3577473362 | 370 |
| Aligned Medical Providers Llc | 9234553116 | 12 |
News Archive
Spectrum Pharmaceuticals, Inc., a commercial-stage biotechnology company with a primary focus in oncology and hematology, and TopoTarget A/S, today announced that the first patient has been dosed in a National Cancer Institute -sponsored Phase 1/2 trial of belinostat in combination with cisplatin, doxorubicin and cyclophosphamide in the first line treatment of advanced or recurrent thymic malignancies.
NPS MedicineWise is encouraging health professionals and community groups to get involved in the upcoming Antibiotic Awareness Week 2016.
In advance of Friday's special meeting, convened by the U.N. Food and Agriculture Organization (FAO), CNN examines the current state of food security around the world and the outlook over the next few years.
Scientists have sequenced the entire genomes of tumors from 50 breast cancer patients and found more than 1,700 gene mutations, most of which were unique to individual patients. The researchers at Washington University in St. Louis and the Siteman Cancer Center suggest that this variability and uniqueness made it difficult to predict outcomes of the cases.
Around a third of patients initially diagnosed with major depressive disorder have their diagnosis changed to bipolar disorder, Polish researchers report.
› Verified 2 days ago
| Entity Name | Apogee Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1760652218 PECOS PAC ID: 2961314265 Enrollment ID: O20031104000688 |
News Archive
Spectrum Pharmaceuticals, Inc., a commercial-stage biotechnology company with a primary focus in oncology and hematology, and TopoTarget A/S, today announced that the first patient has been dosed in a National Cancer Institute -sponsored Phase 1/2 trial of belinostat in combination with cisplatin, doxorubicin and cyclophosphamide in the first line treatment of advanced or recurrent thymic malignancies.
NPS MedicineWise is encouraging health professionals and community groups to get involved in the upcoming Antibiotic Awareness Week 2016.
In advance of Friday's special meeting, convened by the U.N. Food and Agriculture Organization (FAO), CNN examines the current state of food security around the world and the outlook over the next few years.
Scientists have sequenced the entire genomes of tumors from 50 breast cancer patients and found more than 1,700 gene mutations, most of which were unique to individual patients. The researchers at Washington University in St. Louis and the Siteman Cancer Center suggest that this variability and uniqueness made it difficult to predict outcomes of the cases.
Around a third of patients initially diagnosed with major depressive disorder have their diagnosis changed to bipolar disorder, Polish researchers report.
› Verified 2 days ago
| Entity Name | Banner Cancer Center Specialists Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1518253152 PECOS PAC ID: 6103097779 Enrollment ID: O20110913000224 |
News Archive
Spectrum Pharmaceuticals, Inc., a commercial-stage biotechnology company with a primary focus in oncology and hematology, and TopoTarget A/S, today announced that the first patient has been dosed in a National Cancer Institute -sponsored Phase 1/2 trial of belinostat in combination with cisplatin, doxorubicin and cyclophosphamide in the first line treatment of advanced or recurrent thymic malignancies.
NPS MedicineWise is encouraging health professionals and community groups to get involved in the upcoming Antibiotic Awareness Week 2016.
In advance of Friday's special meeting, convened by the U.N. Food and Agriculture Organization (FAO), CNN examines the current state of food security around the world and the outlook over the next few years.
Scientists have sequenced the entire genomes of tumors from 50 breast cancer patients and found more than 1,700 gene mutations, most of which were unique to individual patients. The researchers at Washington University in St. Louis and the Siteman Cancer Center suggest that this variability and uniqueness made it difficult to predict outcomes of the cases.
Around a third of patients initially diagnosed with major depressive disorder have their diagnosis changed to bipolar disorder, Polish researchers report.
› Verified 2 days ago
| Entity Name | Banner Physician Specialists Arizona Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1316228802 PECOS PAC ID: 6204002272 Enrollment ID: O20111222000509 |
News Archive
Spectrum Pharmaceuticals, Inc., a commercial-stage biotechnology company with a primary focus in oncology and hematology, and TopoTarget A/S, today announced that the first patient has been dosed in a National Cancer Institute -sponsored Phase 1/2 trial of belinostat in combination with cisplatin, doxorubicin and cyclophosphamide in the first line treatment of advanced or recurrent thymic malignancies.
NPS MedicineWise is encouraging health professionals and community groups to get involved in the upcoming Antibiotic Awareness Week 2016.
In advance of Friday's special meeting, convened by the U.N. Food and Agriculture Organization (FAO), CNN examines the current state of food security around the world and the outlook over the next few years.
Scientists have sequenced the entire genomes of tumors from 50 breast cancer patients and found more than 1,700 gene mutations, most of which were unique to individual patients. The researchers at Washington University in St. Louis and the Siteman Cancer Center suggest that this variability and uniqueness made it difficult to predict outcomes of the cases.
Around a third of patients initially diagnosed with major depressive disorder have their diagnosis changed to bipolar disorder, Polish researchers report.
› Verified 2 days ago
| Entity Name | Banner Hospital Based Physicians Arizona Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1275889891 PECOS PAC ID: 3274782487 Enrollment ID: O20121003000752 |
News Archive
Spectrum Pharmaceuticals, Inc., a commercial-stage biotechnology company with a primary focus in oncology and hematology, and TopoTarget A/S, today announced that the first patient has been dosed in a National Cancer Institute -sponsored Phase 1/2 trial of belinostat in combination with cisplatin, doxorubicin and cyclophosphamide in the first line treatment of advanced or recurrent thymic malignancies.
NPS MedicineWise is encouraging health professionals and community groups to get involved in the upcoming Antibiotic Awareness Week 2016.
In advance of Friday's special meeting, convened by the U.N. Food and Agriculture Organization (FAO), CNN examines the current state of food security around the world and the outlook over the next few years.
Scientists have sequenced the entire genomes of tumors from 50 breast cancer patients and found more than 1,700 gene mutations, most of which were unique to individual patients. The researchers at Washington University in St. Louis and the Siteman Cancer Center suggest that this variability and uniqueness made it difficult to predict outcomes of the cases.
Around a third of patients initially diagnosed with major depressive disorder have their diagnosis changed to bipolar disorder, Polish researchers report.
› Verified 2 days ago
| Entity Name | Banner - University Hospital Based Physicians Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1750751566 PECOS PAC ID: 1052614294 Enrollment ID: O20160122000508 |
News Archive
Spectrum Pharmaceuticals, Inc., a commercial-stage biotechnology company with a primary focus in oncology and hematology, and TopoTarget A/S, today announced that the first patient has been dosed in a National Cancer Institute -sponsored Phase 1/2 trial of belinostat in combination with cisplatin, doxorubicin and cyclophosphamide in the first line treatment of advanced or recurrent thymic malignancies.
NPS MedicineWise is encouraging health professionals and community groups to get involved in the upcoming Antibiotic Awareness Week 2016.
In advance of Friday's special meeting, convened by the U.N. Food and Agriculture Organization (FAO), CNN examines the current state of food security around the world and the outlook over the next few years.
Scientists have sequenced the entire genomes of tumors from 50 breast cancer patients and found more than 1,700 gene mutations, most of which were unique to individual patients. The researchers at Washington University in St. Louis and the Siteman Cancer Center suggest that this variability and uniqueness made it difficult to predict outcomes of the cases.
Around a third of patients initially diagnosed with major depressive disorder have their diagnosis changed to bipolar disorder, Polish researchers report.
› Verified 2 days ago
| Entity Name | Banner - University Primary Care Physicians Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1154791960 PECOS PAC ID: 2365746450 Enrollment ID: O20160210001728 |
News Archive
Spectrum Pharmaceuticals, Inc., a commercial-stage biotechnology company with a primary focus in oncology and hematology, and TopoTarget A/S, today announced that the first patient has been dosed in a National Cancer Institute -sponsored Phase 1/2 trial of belinostat in combination with cisplatin, doxorubicin and cyclophosphamide in the first line treatment of advanced or recurrent thymic malignancies.
NPS MedicineWise is encouraging health professionals and community groups to get involved in the upcoming Antibiotic Awareness Week 2016.
In advance of Friday's special meeting, convened by the U.N. Food and Agriculture Organization (FAO), CNN examines the current state of food security around the world and the outlook over the next few years.
Scientists have sequenced the entire genomes of tumors from 50 breast cancer patients and found more than 1,700 gene mutations, most of which were unique to individual patients. The researchers at Washington University in St. Louis and the Siteman Cancer Center suggest that this variability and uniqueness made it difficult to predict outcomes of the cases.
Around a third of patients initially diagnosed with major depressive disorder have their diagnosis changed to bipolar disorder, Polish researchers report.
› Verified 2 days ago
| Entity Name | Northern Arizona Healthcare Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1669914552 PECOS PAC ID: 3577473362 Enrollment ID: O20170801003409 |
News Archive
Spectrum Pharmaceuticals, Inc., a commercial-stage biotechnology company with a primary focus in oncology and hematology, and TopoTarget A/S, today announced that the first patient has been dosed in a National Cancer Institute -sponsored Phase 1/2 trial of belinostat in combination with cisplatin, doxorubicin and cyclophosphamide in the first line treatment of advanced or recurrent thymic malignancies.
NPS MedicineWise is encouraging health professionals and community groups to get involved in the upcoming Antibiotic Awareness Week 2016.
In advance of Friday's special meeting, convened by the U.N. Food and Agriculture Organization (FAO), CNN examines the current state of food security around the world and the outlook over the next few years.
Scientists have sequenced the entire genomes of tumors from 50 breast cancer patients and found more than 1,700 gene mutations, most of which were unique to individual patients. The researchers at Washington University in St. Louis and the Siteman Cancer Center suggest that this variability and uniqueness made it difficult to predict outcomes of the cases.
Around a third of patients initially diagnosed with major depressive disorder have their diagnosis changed to bipolar disorder, Polish researchers report.
› Verified 2 days ago
| Entity Name | Aligned Medical Providers Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1386267078 PECOS PAC ID: 9234553116 Enrollment ID: O20200724001162 |
News Archive
Spectrum Pharmaceuticals, Inc., a commercial-stage biotechnology company with a primary focus in oncology and hematology, and TopoTarget A/S, today announced that the first patient has been dosed in a National Cancer Institute -sponsored Phase 1/2 trial of belinostat in combination with cisplatin, doxorubicin and cyclophosphamide in the first line treatment of advanced or recurrent thymic malignancies.
NPS MedicineWise is encouraging health professionals and community groups to get involved in the upcoming Antibiotic Awareness Week 2016.
In advance of Friday's special meeting, convened by the U.N. Food and Agriculture Organization (FAO), CNN examines the current state of food security around the world and the outlook over the next few years.
Scientists have sequenced the entire genomes of tumors from 50 breast cancer patients and found more than 1,700 gene mutations, most of which were unique to individual patients. The researchers at Washington University in St. Louis and the Siteman Cancer Center suggest that this variability and uniqueness made it difficult to predict outcomes of the cases.
Around a third of patients initially diagnosed with major depressive disorder have their diagnosis changed to bipolar disorder, Polish researchers report.
› Verified 2 days ago
| Entity Name | Lifeline Hospitalist Associates Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1265107478 PECOS PAC ID: 3577961606 Enrollment ID: O20211004003129 |
News Archive
Spectrum Pharmaceuticals, Inc., a commercial-stage biotechnology company with a primary focus in oncology and hematology, and TopoTarget A/S, today announced that the first patient has been dosed in a National Cancer Institute -sponsored Phase 1/2 trial of belinostat in combination with cisplatin, doxorubicin and cyclophosphamide in the first line treatment of advanced or recurrent thymic malignancies.
NPS MedicineWise is encouraging health professionals and community groups to get involved in the upcoming Antibiotic Awareness Week 2016.
In advance of Friday's special meeting, convened by the U.N. Food and Agriculture Organization (FAO), CNN examines the current state of food security around the world and the outlook over the next few years.
Scientists have sequenced the entire genomes of tumors from 50 breast cancer patients and found more than 1,700 gene mutations, most of which were unique to individual patients. The researchers at Washington University in St. Louis and the Siteman Cancer Center suggest that this variability and uniqueness made it difficult to predict outcomes of the cases.
Around a third of patients initially diagnosed with major depressive disorder have their diagnosis changed to bipolar disorder, Polish researchers report.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Neychelle Chahal Rocca, MD Po Box 20610, Mesa, AZ 85277-0610 Ph: (480) 985-1093 | Dr Neychelle Chahal Rocca, MD 255 W Brown Rd, Mesa, AZ 85201-3404 Ph: (480) 985-1093 |
News Archive
Spectrum Pharmaceuticals, Inc., a commercial-stage biotechnology company with a primary focus in oncology and hematology, and TopoTarget A/S, today announced that the first patient has been dosed in a National Cancer Institute -sponsored Phase 1/2 trial of belinostat in combination with cisplatin, doxorubicin and cyclophosphamide in the first line treatment of advanced or recurrent thymic malignancies.
NPS MedicineWise is encouraging health professionals and community groups to get involved in the upcoming Antibiotic Awareness Week 2016.
In advance of Friday's special meeting, convened by the U.N. Food and Agriculture Organization (FAO), CNN examines the current state of food security around the world and the outlook over the next few years.
Scientists have sequenced the entire genomes of tumors from 50 breast cancer patients and found more than 1,700 gene mutations, most of which were unique to individual patients. The researchers at Washington University in St. Louis and the Siteman Cancer Center suggest that this variability and uniqueness made it difficult to predict outcomes of the cases.
Around a third of patients initially diagnosed with major depressive disorder have their diagnosis changed to bipolar disorder, Polish researchers report.
› Verified 2 days ago
Gregg Alan Smith, D.O. Hospitalist Medicare: Not Enrolled in Medicare Practice Location: 1042 N Higley Rd, Suite 102-602, Mesa, AZ 85205 Phone: 480-242-6297 Fax: 480-699-3129 | |
Dr. Fayz Yar Khan, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 10238 E Hampton Ave, Mesa, AZ 85209 Phone: 480-354-6463 | |
Dr. Marwan Mohammed Oleiwi, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 6644 E Baywood Ave, Banner Baywood Medical Center, Mesa, AZ 85206 Phone: 480-321-3900 Fax: 480-321-3840 | |
Dr. Pawan A Dhawan, MBBS Hospitalist Medicare: Medicare Enrolled Practice Location: Bdmc/attn: Bmg Hospitalists, 1400 S Dobson Road, Mesa, AZ 85202 Phone: 480-412-6788 Fax: 480-412-6848 | |
Dr. Katelyn Rheault, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 6644 E Baywood Ave, Mesa, AZ 85206 Phone: 602-839-3644 | |
Dr. Lloyd Centino, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: Banner Desert Medical Center Attn Hospitalist, 1400 S Dobson Rd, Mesa, AZ 85202 Phone: 480-412-6788 Fax: 480-412-6848 | |
Dr. Ritesh Kanotra, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 6644 E Baywood Ave, Banner Baywood Medical Center, Mesa, AZ 85206 Phone: 480-321-3900 Fax: 480-321-3840 |